Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.179
-0.004 (-1.92%)
Mar 13, 2025, 3:51 PM EDT - Market open
Virpax Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 6.26 | 11.82 | 9.08 | 7.19 | 2.9 | |
| Research & Development | 5.82 | 5.12 | 9.26 | 4.84 | 1.29 | |
| Operating Expenses | 12.08 | 16.94 | 18.35 | 12.03 | 4.2 | |
| Operating Income | -12.08 | -16.94 | -18.35 | -12.03 | -4.2 | |
| Interest Expense | -0.1 | - | - | -0.09 | -0.15 | |
| Other Non Operating Income (Expenses) | 0.12 | 0.5 | 0.19 | 0 | 0 | |
| EBT Excluding Unusual Items | -12.07 | -16.44 | -18.15 | -12.12 | -4.34 | |
| Legal Settlements | - | - | -2 | - | - | |
| Other Unusual Items | - | - | -1.5 | 0.06 | - | |
| Pretax Income | -12.07 | -15.19 | -21.65 | -12.06 | -4.34 | |
| Net Income | -12.07 | -15.19 | -21.65 | -12.06 | -4.34 | |
| Net Income to Common | -12.07 | -15.19 | -21.65 | -12.06 | -4.34 | |
| Shares Outstanding (Basic) | 4 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 4 | 1 | 1 | 1 | 0 | |
| Shares Change (YoY) | 263.24% | 0.02% | 75.37% | 114.88% | 6.09% | |
| EPS (Basic) | -2.84 | -12.97 | -18.49 | -18.06 | -13.97 | |
| EPS (Diluted) | -2.84 | -12.97 | -18.49 | -18.06 | -13.97 | |
| Free Cash Flow | -16.71 | -9.85 | -17.85 | -14.54 | -1.38 | |
| Free Cash Flow Per Share | -3.93 | -8.41 | -15.24 | -21.78 | -4.46 | |
| EBIT | -12.08 | -16.94 | -18.35 | -12.03 | -4.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.